Medpace Holdings, Inc. MEDP
Set alert
At close · Nov 2
After hours · Nov 2, 4:00 PM ET
- YTD
- +15.40%
- 1 year
- +10.81%
- Open
- 649.06
- Prev close
- 652.01
- Mkt cap
- 18.13B
- Vol
- 198.72K
- Avg vol
- 258.23K
- EPS
- 17.91
- P/E
- 36.19
- Div yield
- 0.00%
More statistics
- Low
- 640.00
- High
- 653.67
- Forward P/E
- 32.64
- Beta
- 1.11
- Short ratio
- 6.09
- Inst. own
- 90.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 8, 2027
- 50-d avg
- 619.12
- 200-d avg
- 529.37
- 1y target
- 651.31
5D chart
Signals (140)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:10 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 3:05 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 3:00 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 2:55 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 2:50 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 2:40 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 2:40 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 2:35 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 2:10 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 2:05 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 2:00 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 1:55 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 1:50 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 1:50 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 1:45 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 1:35 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 1:20 PM | 13 hours ago |
Newest 20 of 140.
News
14 hours ago zacks.com
CON vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the…
3 days ago zacks.com
Medpace (MEDP) is a Great Momentum Stock: Should You Buy?
Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
4 days ago zacks.com
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
1 week ago zacks.com
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
-
1 week ago benzinga.com
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $670
BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $600 to $670.
1 week ago zacks.com
All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy
Medpace (MEDP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
1 week ago zacks.com
Here's Why Medpace (MEDP) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
1 week ago seekingalpha.com
Medpace: Downgrade 'Hold' Revenue Growth Guidance Change And Slightly Lower Backlog Conversion Rate
Medpace Holdings is downgraded from "Buy" to "Hold" due to decelerating growth metrics and underwhelming forward guidance. Q3 2026 Net New Business Awards rose just 10.6%, a sharp slowdown from Q2's…
-
1 week ago benzinga.com
UBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700
UBS analyst Kevin Caliendo maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $673 to $700.
-
1 week ago benzinga.com
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $633
Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $609 to $633.
-
1 week ago benzinga.com
Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $625 to $675.
-
1 week ago benzinga.com
TD Cowen Maintains Hold on Medpace Holdings, Raises Price Target to $673
TD Cowen analyst Charles Rhyee maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $492 to $673.
1 week ago fool.com
Medpace: 3 Key Takeaways for Long-Term Investors
Net new business awards reached $873 million in the third quarter. Ending backlog reached $3.2 billion, up 5.6% year over year.
1 week ago seekingalpha.com
Medpace Holdings, Inc. (MEDP) Q3 2026 Earnings Call Transcript
Medpace Holdings, Inc. ( MEDP ) Q3 2026 Earnings Call October 22, 2026 9:00 AM EDT Company Participants David Ruhe - Associate Director of Financial Planning & Analysis August Troendle - CEO,…
1 week ago marketbeat.com
Medpace Q3 Earnings Call Highlights
Medpace NASDAQ: MEDP reported third-quarter 2026 revenue growth of 8.5% and record net new business awards, while management said the clinical research organization continues to see a strong…
1 week ago benzinga.com
Medpace Hldgs Q3 2026 Earnings Call Transcript
Medpace Hldgs (NASDAQ:MEDP) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
1 week ago zacks.com
Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates
Medpace (MEDP) came out with quarterly earnings of $4.84 per share, beating the Zacks Consensus Estimate of $4.45 per share. This compares to earnings of $3.86 per share a year ago.
1 week ago gurufocus.com
A Look at Medpace Holdings Inc (MEDP) After 6.4% Gain -- GF Value $539.19 vs Price $662.48
On October 21, 2026, Medpace Holdings Inc (MEDP) shares rose 6.4% to $662.48, continuing a strong upward trend that has seen the stock increase 21.4% over the p
1 week ago investors.com
Medpace Slips Despite Third-Quarter Beat, Solid Earnings Outlook
Medpace stock slipped late Wednesday despite beating third-quarter forecasts and issuing an above-Street view for 2026 earnings.
-
1 week ago benzinga.com
Medpace Holdings Raises FY2026 GAAP EPS Guidance from $17.25-$17.95 to $17.97-$18.32 vs $17.60 Est; Narrows FY2026 Sales Guidance from $2.805B-$2.885B to $2.835B-$2.855B vs $2.851B Est
Medpace Holdings (NASDAQ:MEDP) raises FY2026 GAAP EPS guidance from $17.25-$17.95 to $17.97-$18.32 vs $17.60 analyst estimate. Narrows FY2026 sales outlook from $2.805 billion-$2.885 billion to…
-
1 week ago benzinga.com
Medpace Hldgs Q3 EPS $4.84 Beats $4.44 Estimate, Sales $716.000M Beat $715.975M Estimate
Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $4.84 per share which beat the analyst consensus estimate of $4.44 by 9.01 percent. This is a 25.39 percent increase over earnings of $3.86…
1 week ago businesswire.com
Medpace Holdings, Inc. Reports Third Quarter 2026 Results
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Results…
1 week ago benzinga.com
SpaceX Jumps 10%, Nasdaq 100 Rises as AI Trade Returns: Stock Market Today
SpaceX's blowout third quarter and Super Micro's guidance hike revive the AI trade, lifting the Nasdaq 100 as Netflix and AT&T slide on results.
1 week ago benzinga.com
Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test
Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
2 weeks ago benzinga.com
Earnings Volatility Watch: Bloom Energy and Other 11 Stocks Are Priced For Double-Digit Swings
Options price moves above 10% in 12 stocks next week, from TTM Technologies at 20.73% to Stifel Financial at 10.03%. The reports land after a chip and memory selloff that also hit CoreWeave
2 weeks ago zacks.com
CON vs. MEDP: Which Stock Should Value Investors Buy Now?
Investors interested in Medical Services stocks are likely familiar with Concentra Group (CON) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck…
2 weeks ago zacks.com
Medpace (MEDP) Dips More Than Broader Market: What You Should Know
In the latest trading session, Medpace (MEDP) closed at $609.89, marking a -1.64% move from the previous day.
2 weeks ago seekingalpha.com
Medpace: A Shorter, Cleaner Backlog Is Being Mistaken For A Smaller One
Medpace Holdings is misunderstood due to its faster, cleaner backlog burn, which the market misinterprets as a growth ceiling rather than a quality upgrade. Q2 revenues rose 17.2% to $707.3M, with…
-
3 weeks ago benzinga.com
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $665 to $700.
-
3 weeks ago benzinga.com
Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $625
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $600 to $625.
3 weeks ago zacks.com
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors
Medpace (MEDP) concluded the recent trading session at $602.9, signifying a -2.84% move from its prior day's close.
3 weeks ago benzinga.com
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 10 Years
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 21.36% on an annualized basis producing an average annual return of 35.2%. Currently, Medpace Holdings has a…
4 weeks ago defenseworld.net
Medpace Holdings, Inc. $MEDP Stock Holdings Decreased by Argent Capital Management LLC
Argent Capital Management LLC lessened its holdings in Medpace Holdings, Inc. (NASDAQ: MEDP) by 5.3% in the third quarter, according to its most recent filing with the SEC. The institutional investor…
-
1 month ago benzinga.com
Here's How Much $100 Invested In Medpace Holdings 10 Years Ago Would Be Worth Today
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 21.9% on an annualized basis producing an average annual return of 35.51%. Currently, Medpace Holdings has a…
-
1 month ago benzinga.com
UBS Upgrades Medpace Holdings to Neutral, Raises Price Target to $673
UBS analyst Kevin Caliendo upgrades Medpace Holdings (NASDAQ:MEDP) from Sell to Neutral and raises the price target from $405 to $673.
1 month ago zacks.com
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts
In the closing of the recent trading day, Medpace (MEDP) stood at $622.11, denoting a +1% move from the preceding trading day.
1 month ago zacks.com
CON or MEDP: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for…
-
1 month ago benzinga.com
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 15.31% on an annualized basis producing an average annual return of 26.82%. Currently, Medpace Holdings has a…
2 months ago benzinga.com
If You Invested $1000 In Medpace Holdings Stock 10 Years Ago, You Would Have This Much Today
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 22.9% on an annualized basis producing an average annual return of 36.28%. Currently, Medpace Holdings has a…
2 months ago benzinga.com
If You Invested $100 In Medpace Holdings Stock 5 Years Ago, You Would Have This Much Today
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 14.56% on an annualized basis producing an average annual return of 26.38%. Currently, Medpace Holdings has a…
-
3 months ago benzinga.com
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $665
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $586 to $665.
-
3 months ago benzinga.com
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $600
BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $400 to $600.
-
3 months ago benzinga.com
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $609
Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $462 to $609.
-
3 months ago benzinga.com
RBC Capital Maintains Outperform on Medpace Holdings, Raises Price Target to $692
RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $484 to $692.
-
3 months ago benzinga.com
Baird Maintains Neutral on Medpace Holdings, Raises Price Target to $624
Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $547 to $624.
3 months ago benzinga.com
Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook
Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlog growth and higher 2026 guidance.
3 months ago benzinga.com
Brent Tops $100, Alphabet, Tesla Sink Nasdaq 100: Stock Market Today
Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while Alphabet and Tesla earnings revive AI-spending doubts.
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NovoCure (NASDAQ:NVCR) shares moved upwards by 27.7% to $19.88 during Thursday's regular session. The market value of their outstanding shares is at $1.8 billion. The company's, Q2 earnings…
-
3 months ago benzinga.com
Full Transcript: Medpace Hldgs Q2 2026 Earnings Call
On Thursday, Medpace Hldgs (NASDAQ:MEDP) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga…
3 months ago benzinga.com
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday
U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11.4% on better-than-expected results. Other big gainers were NVE Corp (NVEC), Gibo Holdings Ltd…